A prospective cohort study on recovering patients with novel coronavirus pneumonia (COVID-19) by comprehensive treatment of Chinese medicine

Hubei Provincial Hospital of TCM0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Corresponding to diagnosis standards of convalescence of COVID-19 mentioned above;
•(2) Imaging manifestations Fibrous cable-like shadow (patchy) ground glass changes in the lungs,honeycomb sign,reticular changes, increased bronchovascular shadows, pleural effusion,nodular change, any one or more of the above;
•(3) Aged 18-65 years;
•(4) Signing of informed consent.

•1. With other serious primary pulmonary diseases (such as active pulmonary tuberculosis, pneumothorax, pleural effusion, pulmonary embolism and neuromuscular diseases affecting respiratory and motor function);
•2. Severe primary diseases, belong to heart, kidney, lung, endocrine, blood, metabolism and gastrointestinal tract, may affect the patients' participation in the study or the outcome of the study;
•3. A family history of mental illness or a history of mental illness;
•4. Allergic constitution or known drug allergy;
•5. Pregnant or lactating women and those with recent pregnancy plans;
•6. Bedridden for various reasons.

发起方

Hubei Provincial Hospital of TCM